CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Interruption of nucleos(t)ide analogue therapy in HBeAg negative chronic hepatitis B – A new concept to achieve HBsAg decline?
DOI 10.1055/s-0034-1397238
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Höner zu Siederdissen, K Deterding, K Port, B Maasoumy, AA Markova, MP Michael, H Wedemeyer, M Cornberg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Effective suppression of HBV DNA with nucleoside or nucleotide analogues (NA) has shown to delay disease progression in patients with chronic hepatitis B. However, HBsAg loss during NA treatment is a rare event. Thus, treatment duration with NA is not finite and stopping rules before HBsAg loss are not clearly defined, especially in HBeAg negative patients. Methods: We prospectively stopped NA treatment…
Zitieren
Zitierempfehlung
C Höner zu Siederdissen, K Deterding, K Port, B Maasoumy, AA Markova, MP Michael, H Wedemeyer, M Cornberg (2015) Interruption of nucleos(t)ide analogue therapy in HBeAg negative chronic hepatitis B – A new concept to achieve HBsAg decline?. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0034-1397238
Mit CareLit weiterarbeiten